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Abstract
Background: The present study was undertaken to evaluate the potential of the rhizomes of the
Indian medicinal plant, Picrorhiza kurroa in healing indomethacin-induced acute stomach ulceration
in mice and examine its capacity to modulate oxidative stress and the levels of prostaglandin (PGE2)
and EGF during the process.
Methods: Male swiss albino mice, ulcerated with indomethacin (18 mg/kg, p. o., single dose) were
treated up to 7 days with different doses of the methanol extract of P. kurroa rhizomes (designated
as PK). The healing capacity of the most effective dose of PK (20 mg/kg, p. o. × 3 d) was compared
with that of omeprazole (Omez) (3 mg/kg, p. o. × 3 d). The effects of the drug-treatment for one
and three days on the biochemical parameters were assessed by comparing the results with that of
untreated mice of the 1st and 3rd day of ulceration. The stomach tissues of the mice were used for
the biochemical analysis.
Results: The macroscopic indices revealed maximum ulceration on the 3rd day after indomethacin
administration, which was effectively healed by PK. Under the optimized treatment regime, PK and
Omez reduced the ulcer indices by 45.1% (P < 0.01), and 76.3% respectively (P < 0.001), compared
to the untreated ulcerated mice.
Compared to the ulcerated untreated mice, those treated with PK for 3 days showed decreased
the levels of thiobarbituric acid reactive substances (TBARS) (32.7%, P < 0.05) and protein carbonyl
(37.7%, P < 0.001), and increased mucin (42.2%, P < 0.01), mucosal PGE2 (21.4%, P < 0.05), and
expressions of COX-1 and 2 (26.9% and 18.5%, P < 0.05), EGF (149.0%, P < 0.001) and VEGF
(56.9%, P < 0.01). Omez reduced the TBARS (29.4%, P < 0.05), and protein carbonyl (38.9%, P <
0.001), and increased mucin (38.3%, P < 0.01), without altering the other parameters significantly.
Conclusion: PK (20 mg/kg, p. o. × 3 days) could effectively heal indomethacin-induced stomach
ulceration in mice by reducing oxidative stress, and promoting mucin secretion, prostaglandin
synthesis and augmenting expressions of cyclooxygenase enzymes and growth factors.
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Background
Gastrointestinal toxicity associated with the nonsteroidal
anti-inflammatory drugs (NSAIDs) is an important medi-
cal problem despite recent pharmaceutical advances [1].
Besides inducing gastric ulceration, the NSAIDs also
appear to inhibit ulcer healing [2,3]. Consequently, pre-
vention of gastrointestinal disorder continues to be of
concern for both clinical practitioner and researchers. In
spite of their efficacy in managing the NSAID induced gas-
tric ulceration, the currently available synthetic anti-ulcer
drugs confer side effects, and are also expensive especially
for the rural population. To this end, we have reported
promising anti-ulcerogenic activity of several plant prod-
ucts [4-6].
Picrorhiza kurroa (family: Scrofulariaceae, common name:
Picrorhiza, katuka, kutki) is a small perennial herb grow-
ing in the hilly parts of the North-Western Himalayan
region in India and Nepal. The leaf, bark and the under-
ground parts of the plant, mainly rhizomes are widely
used in the traditional Indian (Ayurvedic) systems of
medicine since ancient times. Although it shows anti-oxi-
dant, anti-inflammatory, and immunomodulatory activi-
ties, it is most valued for its hepatoprotective effect. The
bitter rhizomes of Picrorhiza have been used for thousands
of years in India to treat people with indigestion [7], and
constipation due to insufficient digestive secretion [8].
Picrorhiza is considered as a trophorestorative herb for the
liver, as well as a potent immune stimulant [9]. Its constit-
uent, picroliv is also reported to possess choleretic effect
[10], and prevent hepatic injury caused by ethanol [11],
chemicals [12] and microorganism [13].
The primary aim of this investigation was to study the
healing property of the methanol extract of P. kurroa rhi-
zome (designated as PK) against indomethacin-induced
acute gastric ulceration of mice vis-à-vis that of the com-
mercial drug, omeprazole (Omez). Indomethacin, a rep-
resentative of the nonsteroidal anti-inflammatory drug
(NSAID) family, causes gastric ulcers through various
processes, including generation of ROS, inhibition of
prostaglandin synthesis, infiltration of polymorphonu-
clear leukocytes, induction of apoptosis, and initiation of
lipid peroxidation [14,15]. Hence, the ulcer healing
capacities of the drugs, assessed by histopathology, was
correlated with their effects in reducing the indomethacin-
induced oxidative stress. The antioxidant activity of the
test samples was assayed in terms of their ability to protect
oxidative damages to lipids, proteins, and thiol-depend-
ent antioxidant defense in gastric tissues. Further, the
NSAIDs-induced gastropathy is also attributed to the
decreased synthesis of the prostaglandins [16]. Conse-
quently, the role of the test samples in increasing mucus
secretion, and expression of epidermal growth factor




The rhizome of P. kurroa (designated as PK), procured
from the local market was used for the present work. The
plant was taxonomically identified (accession no.
324139) by the Botanical Survey of India, Indian Botani-
cal Garden, Kokata, India.
Chemicals
2-Thiobarbituric acid (TBA), ethanol, butanol and ethyl
acetate were procured from E. Merck (Mumbai, India),
while trichloroacetic acid (TCA) was from Thomas Baker
(Mumbai, India). Alcian blue, indomethacin, bovine
serum albumin (BSA), haematoxylene, alum, eosin,
butylated hydroxytoluene (BHT), guanidine hydrochlo-
ride, trifluoroacetic acid (TFA), omeprazole (Omez), 3,3 '-
diaminobenzidine (DAB), rabbit anti-mouse EGF and
Trizma base were procured from Sigma Chemicals (St.
Louis, MO, USA). Other reagents used were 35% hydro-
gen peroxide (Lancaster, Morecambe, U.K.), 2,4-dinitro-
phenyl hydrazine (DNPH), disodium hydrogen
phosphate and sodium dihydrogen phosphate (BDH,
Pool Dorset, U.K.), sucrose and 5,5'-dithiobis-2-nitroben-
zioc acid (DTNB) (SRL, Mumbai, India), horse and goat
serum (Banaglore Genie, Banaglore, India), PGE2 metab-
olite kit (Cayman Chemical, Michigan, USA) and peroxi-
dase conjugated goat anti-rabbit IgG (EMD Biosciences,
Sandiego, USA).
Instrumentation
The absorbance spectrophotometry was carried out at
25°C using a Jasco V-550 UV-Vis spectrophotometer.
Wavelength scans and absorbance measurements were
made in 1 ml quartz cells of 1 cm path length.
Preparation of plant extracts
The air-dried rhizomes of P. kurroa (250 g) were chopped
into fine pieces, soaked in methanol (1 l) for two days and
the supernatant decanted. After repeating the entire proc-
ess three times, the combined extracts were filtered
through a nylon mesh, and evaporated in vacuo and
finally lyophilized. The crude extract, designated as PK
throughout the manuscript, was stored in a vacuum dessi-
cator.
Preparation of the drugs
The drugs were prepared from PK and Omez as aqueous
suspensions in 2% gum acacia as the vehicle, and admin-
istered to the mice orally.BMC Complementary and Alternative Medicine 2008, 8:3 http://www.biomedcentral.com/1472-6882/8/3
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Pharmacological tests
Animals and experimental protocol for ulceration
Male swiss albino mice were bred at Dr. B. C. Roy Post
Graduate Institute of Basic Medical Sciences, Kolkata,
India and BARC Laboratory Animal House Facility, Mum-
bai, India. These were procured after obtaining clearance
(Post Graduate Institute of Basic Medical Sciences, Kolk-
ata Animal Ethics Committee 507/CPCSEA, Sanction No.
IAEC/SB-2/2004/UCM-16, dated 06.15.04 and BARC
Animal Ethics Committee (BAEC), laboratory animal
facility. sanction no. BAEC/03/05, dated 11.07.05) from
the respective Animal Ethics Committees of the two cen-
tres and were handled following International Animal
Ethics Committee Guidelines. The 6–8 weeks old mice
(25–30 g) were reared on a balanced laboratory diet as per
NIN, Hyderabad, India and given tap water ad libitum.
They were kept at 20 ± 2°C, 65–70% humidity, and day/
night cycle (12 h/12 h). At the beginning of each experi-
ment, all animals were identified by typical notches in the
ear and limbs and then randomized. This was done to per-
form all the experiments in a blinded fashion. Ulceration
in the mice was induced by administering indomethacin
(18 mg/kg, p. o.) dissolved in distilled water and sus-
pended in the vehicle, gum acacia (2%) as a single dose.
Our studies with 5, 10, 15, 18, 20, 25 and 30 mg/kg, p. o.
of indomethacin revealed that the lowest doses (5 and 10
mg/kg) provided minor ulceration after 6 h of its admin-
istration, while the higher doses (25 and 30 mg/kg) led to
mortality. The chosen dose (18 mg/kg) produced optimal
ulceration, with inflammation and mucosal insult, with-
out causing any mortality to mice. The animals were
deprived of food but had free access to tap water 24 h
before ulcer induction.
Standardization of drug dose
For the standardization of drug doses, PK (5, 10, 20, and
40 mg/kg) was given as a single dose per day up to seven
days. The first dose of PK and Omez were given 6 h after
the indomethacin administration. In the subsequent six
days, the test samples were given at 9 AM on each day. Five
mice were taken in each group and each experiment was
repeated three times. The mice were sacrificed on the 1st,
3rd, 5th and 7th days, 4 h after administering the last dose
of PK. The extent of ulcer healing was assessed from the
macroscopic damage scores (MDS) of the untreated and
treated ulcerated mice on the respective days. The opti-
mized treatment regime (drugs dose and period of treat-
ment) were assessed from the MDS of the groups of mice
receiving the above treatment.
Assessment of ulceration and healing from MDS
The mice were sacrificed after an overdose with thiopen-
tal. The stomach from the normal and treated groups were
removed rapidly, opened along the greater curvature, and
thoroughly rinsed with normal saline. The ulcerated gas-
tric mucosal areas were visualized using a transparent
sheet and a dissecting microscope. The MDS was assessed
[17] by grading the gastric injury on a 0–4 scale, based on
the severity of hyperemia and hemorrhagic lesions: 0 –
almost normal mucosa, 0.5 – hyperemia, 1 – one or two
lesions, 2 – severe lesions, 3 – very severe lesions, 4 –
mucosa full of lesions. (lesions – hemorrhagic erosions,
hyperemia – vascular congestions). The experiments were
performed by two investigators blinded to the group and
treatment of animals. The sections were coded to elimi-
nate an observer bias. Data for the analyses are presented
as the mean ± SEM from the review of a minimum of three
sections per animal and five animals per group.
Studies on the biochemical parameters
The MDS results revealed maximum ulcer healing after
three days of drug treatment. The stomach ulceration in
the untreated mice also reached peak on the 3rd day after
indomethacin administration. Hence, we assessed the
biochemical parameters under the optimized treatment
regime [PK (20 mg/kg) and Omez (3 mg/kg)] up to the 3rd
day of ulceration only. For this, the following seven
groups each containing 5 mice were selected from those
used for the MDS assay and the data shown are derived
from three replicates:
Group I – normal control mice; Group II – ulcerated mice,
and sacrificed after 10 h (considered as one day); Group
III – ulcerated mice, and sacrificed on the 3rd day; Group
IV-V – ulcerated mice, treated with PK and Omez respec-
tively for 1 day, and sacrificed 4 h after administration of
test samples; Group VI-VII – ulcerated mice, treated with
PK and Omez respectively for 3 days, and sacrificed in the
3rd day, 4 h after the last dose of the test samples.
Quantification of protein and lipid damages during ulceration and 
healing
The glandular stomach tissues were pooled from five ani-
mals for each tissue, rinsed with appropriate buffer and
used for biochemical studies. The wet weights of the tis-
sues were recorded and the experiments were carried out
in triplicates. The glandular portions from the control,
ulcerated and drug-treated mice taken at different time
intervals were homogenized with a glass-teflon homoge-
nizing tube in a 50 mM phosphate buffer, pH 7.4 and cen-
trifuged at 1200 × g to obtain the supernatant. The
amount of protein carbonyls in the tissue homogenate,
was determined following a reported method [18]. DNPH
(4 ml, 10 mM) in 2 M HCl was added to the supernatant
(1.0 ml), which was incubated for 1 h with intermittent
shaking. Ice-cold 20% aqueous TCA solution (5 ml) was
added and the mixture incubated for 15 min. The precip-
itated protein was washed 3 times with ethanol-ethyl ace-
tate (1:1), dissolved in 1 ml of a solution containing 6 M
guanidine HCl in 20 mM potassium phosphate (monoba-BMC Complementary and Alternative Medicine 2008, 8:3 http://www.biomedcentral.com/1472-6882/8/3
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sic) adjusted to pH 2.3 with trifluoroacetic acid. After cen-
trifuging, the absorbance of the supernatant was read at
362 nm (∈ = 2.2 × 104 M-1 cm-1).
For the analysis of lipid peroxidation (in terms of TBARS),
a 10% homogenate from each of the respective samples
was prepared in a buffer (320 mM sucrose, 5 mM HEPES,
20 mM EDTA and 0.01% BHT). These were subjected to
differential centrifugation (1200 × g and 12000 × g) to
obtain the mitochondrial pellets, which were washed with
the buffer (150 mM KCl and 20 mM phosphate buffer)
and finally suspended in a 50 mM phosphate buffer, pH
7.4. The mitochondrial membrane fraction (1 ml) was
treated with TCA-TBA-HCl (2 ml, 15% TCA, 0.375% TBA,
0.25 N HCl) containing 0.01% BHT, heated on a boiling
water bath for 15 min, cooled and centrifuged. The
absorbance of the supernatant was measured at 535 nm
(∈ = 1.56 × 105 M-1 cm-1) [19].
Measurement of non-protein thiol (NP-TSH)
Following a reported method [20], the gastric mucosal
NP-TSH was measured. Briefly, fundic stomach homoge-
nates from the control, ulcerated, drug-treated mice were
made in 0.2 M Tris-HCl buffer, pH 8.2 containing 20 mM
EDTA and centrifuged. An aliquot of the homogenate (1
ml) was precipitated with ice-cold 20% TCA (1 ml) and
centrifuged. The supernatant (1 ml) was added to 2 ml of
0.8 M Tris-HCl buffer, pH 9 containing 20 mM EDTA and
mixed with 0.1 ml of 10 mM DTNB. The absorbance of
the yellow chromogen at 412 nm (∈ = 13.6 × 104 M-1 cm-
1) was read.
Mucin assay
Following a reported method [21], the free mucin in the
gastric tissues was estimated. Briefly, the glandular por-
tion of the stomach was separated from the lumen of the
stomach, weighed and transferred immediately to 10 ml
of 0.1% w/v Alcian blue (Ab) solution (in 0.16 M sucrose
solution buffered with 0.05 mM sodium acetate solution,
pH adjusted to 5.8). After staining for 2 h, the excess dye
was removed from the tissue by two successive rinses with
10 ml of 0.25 M sucrose solution. The dye complexed
with the gastric wall mucus was extracted with 10 ml of
0.5 M magnesium chloride by intermittent shaking (1
min) at 30 min intervals for 2 h. The blue extract (2 ml)
was vigorously shaken with an equal volume of diethyl
ether. The resulting emulsion was centrifuged at 3600 rpm
for 10 min, and the absorbance of the aqueous layer was
read at 580 nm. The quantity of Ab extracted per g of wet
glandular tissue was calculated from a standard curve pre-
pared using various concentrations of Ab.
COX-1 and COX-2 expression assay
Within 30 min of harvesting, the ulcerated portions of the
stomach tissues were fixed in neutral-buffered 10% for-
mol saline and sectioned. After 24 h of fixation followed
by embedding in a paraffin block, it was cut into sections
of 5 micron onto a glass slide and the expressions of COX-
1 and COX-2 were quantified following a reported proce-
dure [22], with slight modification. After deparaffiniza-
tion in xylene, the sections were treated with a graded
series of alcohol and subsequently rehydrated in PBS at
pH 7.5. The sections were sequentially treated with 3%
hydrogen peroxide in PBS, and protein blockers (5%
bovine serum albumin, 5% normal goat serum in PBS),
and incubated overnight at 4°C with primary antibody
(mouse anti-COX-1 and COX 2, 1:200). After incubation
for 2 h at room temperature with peroxidase conjugated
rabbit anti-mouse secondary antibody (1:500), a positive
reaction was detected by exposure to stable DAB for 2 to 5
min. In control sections, antibodies were omitted, and
only PBS was added. After counterstaining the slides with
Meyer's hematoxylin, the intensities of colored immu-
nolocalized products were evaluated using Biovis MV500
software. Five areas from each section were scanned and
the integrated optical density (IOD) in each area was cal-
culated. The IOD of the negative control was subtracted
from the IOD of each experimental section for each ani-
mal in all the groups.
Prostaglandin assay
Following harvesting of the stomach, the corpus (full
thickness) was excised, weighed (100 mg) and suspended
in 10 mM sodium phosphate buffer, pH 7.4 (1 ml). The
tissue was minced finely with scissors and incubated at
37°C for 20 min. After centrifugation (9000×g), the pros-
taglandin E2 (PGE2) levels in the supernatant were meas-
ured by ELISA [23], and the concentrations are expressed
as pg/mg protein.
EGF expression assay
The immunostaining of EGF was carried out [22] follow-
ing a similar method used for COX-1 and COX-2, with
minor modifications. In this case, after blocking the
endogenous peroxidase and treatment with the protein
blockers, the tissue sections were incubated overnight at
4°C with primary antibody at the appropriate dilution. In
control sections, only PBS was added omitting the anti-
bodies. After incubation for 1 h at room temperature with
peroxidase conjugated goat anti-rabbit IgG, a positive
reaction was detected by exposure to DAB for 2 to 5 min.
After counterstaining the slides with Meyer's hematoxylin,
the intensities of colored immunolocalized products were
quantified using Biovis MV500 software. Five areas from
each section were scanned and the integrated optical den-
sity (IOD) in each area was calculated. The IOD of the
negative control was subtracted from the IOD of each
experimental section for each animal in all the groups.BMC Complementary and Alternative Medicine 2008, 8:3 http://www.biomedcentral.com/1472-6882/8/3
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Assay of serum VEGF
The serum VEGF was measured using the blood samples
drawn from the descending aorta, with commercially
available ELISA kits following manufacturer's instruction.
Gastric secretory assay (pylorous ligation model)
To study the effects of the test drugs on gastric secretion,
the pyloric ligation of the stomach standardized in our
laboratory was performed. One group of mice (experi-
mental control) received 2% gum acacia in distilled water
(0.2 ml per mice, p.o.), while the different treatment
groups were given PK (20 mg/kg × 3 d), Omez (3 mg/kg ×
3 d), indomethacin (18 mg/kg × 1 d) as such or along with
PK (20 mg/kg × 3 d), Omez (3 mg/kg × 3 d) respectively.
On the 3rd day, the abdomen of the animals was opened
under light ether anesthesia for pyloric ligation (PL). After
closure of the abdomen, the animals were put into cages
under light restraint and allowed to recover from the
anesthesia. After 6 h, the animals were sacrificed, the
abdomen was opened and a ligature was placed around
the esophagus. Stomach was removed and the contents
were drained into a graduated centrifuge tube after mak-
ing a small nick along the greater curvature adjacent to
pyloric ligation. The gastric contents were collected, meas-
ured, centrifuged, and subjected to biochemical analysis.
Statistical analysis
The data are presented as mean ± SEM. Parametric data
which includes all the biochemical parameters were ana-
lyzed using a paired 't' test for the paired data or one way
analysis of variance (ANOVA) followed by a Dunnet mul-
tiple comparisons post test. Nonparametric data (macro-
scopic scoring) were analyzed using Kruskal-Wallis test
(nonparametric ANOVA) followed by a Dunn's multiple
comparisons post test. A probability value of P < 0.05 was
considered significant. The IC50 value of PK was estimated
using the Probit analysis and the significance level of the
analyses was investigated by the chi-square test.
Results
Extraction and phytochemical analysis
The extraction process yielded the methanol extract, PK in
12.57% w/w yield. The TLC analysis of PK revealed it to be
a complex mixture of a large number of organic com-
pounds, most of these being present as glycosides as
revealed by Molisch's test. Presence of apocynin,
andorsin, picrosides I and II, and katukoside along with
other unidentified compounds in PK was confirmed by
comparison of its TLC profile with those of the authentic
samples.
Standardization of dose of PK for gastric ulcer healing in 
mice
The dose of PK for effective ulcer healing were optimized
by carrying out the treatment with PK (5, 10, 20 and 40
mg/kg) up to seven days and comparing the MDS values
of the treated and untreated mice on the respective days.
The time course of the extent of stomach ulceration (as
revealed from MDS values) and its prevention by different
doses of PK are shown in Fig. 1. The mice receiving vehicle
only showed no mucosal lesions. Treatment of mice with
indomethacin (18 mg/kg) produced typical time-depend-
ent acute lesions in the gastric mucosa. The ulceration
reached maximum on the 3rd day of ulceration when the
MDS value increased by 162.1% compared to that on day
one (P < 0.001). Thereafter, there was a gradual recovery
due to natural healing, and on the 7th day after ulceration,
the MDS value was reduced by 49.2% compared to that
on day one (P < 0.01).
PK, at all the chosen doses showed maximum ulcer heal-
ing on the 3rd day of ulceration, and the effect was dose-
dependent. Compared to respective ulcerated controls,
the MDS reductions (45.1%–52.9%, P < 0.01) by PK (20
and 40 mg/kg) were similar, and significantly better than
that at its lower dose (10 mg/kg). The effect of PK (5 mg/
kg) was insignificant. Under similar conditions, treatment
with Omez (3 mg/kg) for 3 days reduced the MDS value
by 76.3% (P < 0.001) compared to that of the group III
mice. The healing observed on extending the treatment up
to seven days with PK was better than that observed with
the three-day treatment regime. However, a major part of
this was due to autohealing, with less contribution by PK.
Overall, treatment with PK (20 mg/kg) and Omez (3 mg/
kg) for 3 days after ulcer induction provided optimal ulcer
healing. In view of these, all subsequent experiments were
carried out with the same treatment regime. The chosen
dose of Omez, which is also the recommended therapeu-
tic dose for humans was optimized by us [6].
For the untreated mice, peak ulceration (maximum MDS)
was observed on the third day of indomethacin adminis-
tration. Hence, this time point was selected to find out the
IC50 value of PK. Considering the MDS values of the 3rd
day ulcerated untreated mice as 100%, the IC50 value of
PK was found to be 23.30 ± 3.50 mg/kg.
Qualitative assessment
The macroscopic examinations revealed that indometh-
acin administration led to a marked damage to the glan-
dular portion of the mice gastric mucosa. Within 6 h
following indomethacin administration, superficial ero-
sion and mild inflammation in the stomach was observed
indicating acute ulceration. On the day of ulcer induction,
loss of foveolar structure along with cryptic architecture
was the prominent feature in most of the untreated mice.
Also, mild inflammatory infiltrate containing neutrophils
was observed in the lamina propria. Treatment with bothBMC Complementary and Alternative Medicine 2008, 8:3 http://www.biomedcentral.com/1472-6882/8/3
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PK and Omez even for one day restricted the damage with
patchy areas of denuded structural epithelium.
Indomethacin induced gastropathy became much pro-
nounced on the third day showing punched out multiple
areas of ulceration with inflammatory infiltrate contain-
ing neutrophils and macrophages in the mucosa, sub-
mucosa and muscle coat along with hemorrhagic serosa.
A large number of abnormal cells with altered nucleus to
cytoplasm ratio were noticed. Treatment with PK and
Omez for 3 days led to reduced number of inflammatory
cells along with an increased number of healthy normal
cells in the gastric mucosa, as well as submucosa, serosa
and muscle layers with minimum mucosal congestion.
Table 1: The effect of PK and Omez on the levels of TBARS, protein carbonyls, non-protein thiol, and mucin in the ulcerated gastric 
tissue of micea on day one of ulceration
Parameters Group I mice normal 
control
Group II 1st day ulcerated 
control
Group III PK-treated Group IV Omez-treated
TBARS (nmoles/mg protein) 0.85 ± 0.03 1.18 ± 0.05c 0.94 ± 0.06d 0.89 ± 0.07d
protein carbonyls (nmoles/mg protein) 1.08 ± 0.05 1.62 ± 0.09b 1.49 ± 0.12 1.53 ± 0.07
NP-TSH (nmoles/mg tissue) 1.99 ± 0.09 1.66 ± 0.08b 1.86 ± 0.08 1.81 ± 0.09
mucin (μg/g tissue) 335.03 ± 14.43 213.02 ± 0.59b 240.33 ± 20.49 253.33 ± 14.53d
aStomach ulceration in mice was induced by oral administration of indomethacin (18 mg/kg). PK (20 mg/kg/day × 1 day) and Omez (3 mg/kg/day × 1 
day) were used as the test samples. The assays were carried out 4 h after the administration of the test samples. The values are mean ± SEM (n = 
15). bP < 0.05, cP < 0.01 compared to normal mice; dP < 0.05 compared to the group II mice.
The time course of stomach ulceration and its prevention by different doses of PK Figure 1
The time course of stomach ulceration and its prevention by different doses of PK. Stomach ulceration in mice was induced by 
oral administration of indomethacin (18 mg/kg body weight). Different doses of PK were used for the experiments. The ulcer 
indices were measured on different days 4 h after the last dose of PK and the values are mean ± S.E.M. (n = 15). aP < 0.01, bP < 
0.001 compared to 1st day ulcerated untreated mice; cP < 0.01, dP < 0.001 compared to the group III mice.BMC Complementary and Alternative Medicine 2008, 8:3 http://www.biomedcentral.com/1472-6882/8/3
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Effect of PK and Omez on lipid peroxidation and protein 
oxidation in stomach tissue
The effects of indomethacin intake alone and following
administration of PK and Omez on the extent of lipid per-
oxidation (measured in terms of TBARS), protein oxida-
tion (measured in terms of protein carbonyl content), the
thiol-dependent defense system (NP-TSH) and mucin
content in the gastric tissues of mice are shown in Table 1
and Table 2.
Indomethacin administration markedly stimulated lipid
peroxidation in gastric tissues, elevating the TBARS con-
tent by 38.8% (P < 0.01) and 53% (P < 0.001) respectively
on the 1st and 3rd day of ulceration, compared to that of
the normal control mice. Treatment with PK and Omez
showed immediate effect, reducing the TBARS content by
20.3% and 24.6% respectively compared to the group II
mice (P < 0.05). Treatment with PK and Omez for three
days reduced it by 32.7% and 29.4% compared to the
group III mice (P < 0.05).
Compared to the normal value, the protein carbonyl con-
tent of the ulcerated mice was higher (50%) on the first
day (P < 0.05) which increased by 120.3% at peak ulcera-
tion (P < 0.001). None of the test drugs showed immedi-
ate impact on day one. However, after treatment for three
days, PK and Omez reduced the protein carbonyl contents
by 37.7% and 38.9% compared to that of the group III
mice (P < 0.001).
Effect of PK and Omez on NP-TSH in stomach tissue
Indomethacin administration to mice depleted the NP-
TSH level significantly on the day of ulcer induction itself
compared to that in normal mice (16.6%, P < 0.05). How-
ever, there was no further reduction in the level at peak
ulceration. Treatment with the PK and Omez for three
days increased the NP-TSH content by 19.1% and 18.5%
compared to that of the group III mice (P < 0.05).
Effect of PK and Omez on mucin contents in stomach 
tissue
The indomethacin administration immediately reduced
the mucin secretion in the ulcerated mice compared to
that in normal mice (36.4%, P < 0.05) and the status
remained unaltered even at peak ulceration. Compared to
that of the group II mice, Omez showed immediate effect
augmenting the mucin level by 18.9% (P < 0.05) while
the effect of PK was less. Prolonging the treatment for
three days augmented the mucin level significantly by
42.2% and 38.3% in both PK and Omez treated groups (P
< 0.01).
Autohealing of gastric ulceration and effect on 
biochemical parameters
We also followed natural recovery in absence of any treat-
ment up to 7 days. The autohealing began five days after
the ulcer induction but was more pronounced on the 7th
day, when noticeable regeneration atypia in the gastric
gland was observed (Figure nor shown). This also sug-
gested that the ulceration was acute. The rate of healing in
the untreated mice was significantly slower compared to
the drug-treated animals. The autohealing for 7 days was
accompanied with reduction of TBARS (32%) and protein
carbonyl (35%) along with increase in the mucin content
(11%) compared to those in the group III mice (three day-
untreated). The values were significantly less than that
observed with the mice treated with PK and Omez for
three days (P < 0.05).
Effect of PK and Omez on COX isoforms
Quantification of the immunopositive areas for the COX
isoforms revealed reduced expression of COX-1 (28.5%, P
< 0.05), and COX-2 (37.6%, P < 0.01) in the ulcerated
untreated mice on the day of ulcer induction itself, com-
pared to normal mice (Fig. 2 and Fig. 3). At peak ulcera-
tion, the expressions of COX-1 and COX-2 were lowered
by 52.1% and 54.3% respectively (P < 0.01) compared to
the normal values. None of the test samples had any
immediate effect on the expression of the mucosal COX
isoforms. However, on prolonging the treatment for three
days, PK increased the expression of COX-1 and COX-2
Table 2: The effect of PK and Omez on the levels of TBARS, protein carbonyls, non-protein thiol, and mucin in the ulcerated gastric 
tissue of micea on day three of ulceration
Parameters Group I normal control Group III 3rd day ulcerated 
control
Group V PK-treated Group VI Omez-treated
TBARS (nmoles/mg protein) 1.02 ± 0.06 1.53 ± 0.06c 1.03 ± 0.09d 1.08 ± 0.05d
Protein carbonyls (nmoles/mg protein) 1.18 ± 0.07 2.61 ± 0.17c 1.62 ± 0.10f 1.59 ± 0.09f
NP-TSH (nmoles/mg tissue) 2.06 ± 0.09 1.73 ± 0.09 2.06 ± 0.14d 2.05 ± 0.1d
mucin (μg/g tissue) 343.30 ± 16.91 213.29 ± 17.91b 303.34 ± 17.4e 295.06 ± 15.62e
aStomach ulceration in mice was induced by oral administration of indomethacin (18 mg/kg). PK (20 mg/kg/day × 3 days) and Omez (3 mg/kg/day × 
3 days) were used as the test samples. The assays were carried out on day three of ulceration, 4 h after the last dose of the drug. The values are 
mean ± SEM (n = 15). bP < 0.05, cP 0.001 compared to normal mice, dP < 0.05, eP < 0.01, fP < 0.001 compared to the group III mice.BMC Complementary and Alternative Medicine 2008, 8:3 http://www.biomedcentral.com/1472-6882/8/3
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isoforms by 26.9% and 18.5% respectively compared to
that in the group III mice (P < 0.05). The effect of PK was
better (P  < 0.05) than that of Omez, which increased
expression of the enzymes insignificantly.
Effect of PK and Omez on PGE2 level
The synthesis of mucosal PGE2 was markedly suppressed
by 33.4% (P < 0.05) and 41.0% (P < 0.01) on the 1st and
3rd day of ulceration, compared to that in the normal
mice. None of the test samples showed any immediate
effect in modulating the PGE2 level. However, on prolong-
ing the treatment for 3 days, the mucosal synthesis of
PGE2 in the PK-treated mice increased significantly by
21.4% (P < 0.05) compared to that of the group III mice.
The effect of PK was significantly (P < 0.05) better than
that of Omez, which increased the PGE2 level marginally
(8.3%). The results are summarized in Fig. 4.
Effect of PK and Omez on EGF expression
Administration of the test drugs led to an increased
expression of EGF in mucosa of the ulcer margin. EGF was
found to be immunolocalized in proliferative zone cells
and in some parietal cells in the gastric oxyntic mucosa
(Fig 5).
Compared to the normal mice, the expressions of EGF
increased by ~2.7 and 3.6 folds respectively (P < 0.001)
for the groups II and III ulcerated mice. However, treat-
ment with PK for one and three days augmented the
expression of EGF further by 98.1% and 149.0% (P  <
0.001) compared to that in the respective ulcerated con-
trol mice. PK showed significantly better effect than Omez
(P < 0.01), which increased the EGF expression by 11.6%
compared to that of group III mice. The results are sum-
marized in Fig. 6.
Effect of PK and Omez on VEGF expression
Compared to the normal unulcerated mice, the serum
VEGF levels of the ulcerated mice was reduced by 10.3%
and 44.1% (P < 0.01) respectively on the 1st and 3rd days
of ulceration. Treatment with PK for 3 days increased
(56.9%,  P  < 0.01) it significantly, compared to the
untreated ulcerated mice (Fig. 7). The effect of PK was sig-
nificantly better compared to that of Omez (P < 0.01).
Comparative time dependent activity of PK and Omez in regulating the expression of tissue COX-1 isoform in acute gastric  ulcerated mice Figure 2
Comparative time dependent activity of PK and Omez in regulating the expression of tissue COX-1 isoform in acute gastric 
ulcerated mice. The COX-1 expression was quantified using Biovis MV500 software. Data are expressed as means ± SEM for 
fifteen mice. aP < 0.05, bP < 0.01 compared to normal mice, cP < 0.05 compared to the respective ulcerated mice, dP < 0.05 
compared to the Omez-treated mice. N – normal mice, UU – ulcerated untreated mice, PK – ulcerated PK-treated mice, 
Omez – ulcerated Omez-treated mice.BMC Complementary and Alternative Medicine 2008, 8:3 http://www.biomedcentral.com/1472-6882/8/3
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Effect of PK and Omez on gastric secretion
Compared to the untreated PL mice, those receiving
indomethacin showed an increased volume of gastric
juice (88%, P < 0.01) and acid output (39.8%, P < 0.05).
Treatment with PK reduced these parameters by 18.7% (P
< 0.05) and 19.7% (P < 0.05) while Omez reduced these
by 43.7% (P < 0.01) and 32.3% (P < 0.05). The pH of the
gastric contents that was substantially reduced by
indomethacin was restored to that of the experimental
control mice (Table 3).
Discussion
Ulcer healing is a complex process involving various fac-
tors. The gastrotoxicity of the NSAIDs including
indomethacin in animals can be attributed to their ability
to induce the reactive oxygen metabolites. They also delay
ulcer healing by reducing the prostaglandin (PG) level
[2,24] and preventing the PG-mediated angiogenesis. In
addition, the NSAIDs decrease gastric mucus production
[25] resulting in hemorrhagic ulcer. Release of preformed
mucus also plays a role in promoting epithelial recovery
after acute injury by forming a mucoid cap beneath which
re-epithelization occurs. The growth factors play a crucial
role in ulcer healing by potentiating angiogenesis, and
increasing the release of gastric mucin. Thus, drugs that
arrest ulcer progression by antioxidant action, and also
promote secretion of PGE2, gastric mucus, and growth fac-
tors would accelerate gastric ulcer healing.
Our histopathological examinations revealed that admin-
istration of indomethacin caused marked damage to the
gastric mucosa within 6 h with elongated haemorrhagic
lesions, confined to the glandular portion. Maximum
ulcerative damage was observed on the 3rd  day after
administration of indomethacin. The acute nature of
ulceration was evident from natural recovery of the gastric
tissues even without any treatment, although the process
was slow.
In comparison, the mice treated with PK and Omez
showed significantly faster and better healing within three
days. Overall, PK and Omez C (at all doses) showed max-
imum efficacy on the 3rd day of treatment. Interestingly,
the accelerated healing by the drugs was also evident
Comparative time dependent activity of PK and Omez in regulating the expression of tissue COX-2 isoform in acute gastric  ulcerated mice Figure 3
Comparative time dependent activity of PK and Omez in regulating the expression of tissue COX-2 isoform in acute gastric 
ulcerated mice. The COX-2 expression was quantified using Biovis MV500 software. Data are expressed as means ± SEM for 
fifteen mice. aP < 0.01 compared to normal mice, bP < 0.05 compared to the respective ulcerated mice, cP < 0.05 compared to 
the Omez-treated mice. N – normal mice, UU – ulcerated untreated mice, PK – ulcerated PK-treated mice, Omez – ulcerated 
Omez-treated mice.BMC Complementary and Alternative Medicine 2008, 8:3 http://www.biomedcentral.com/1472-6882/8/3
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within 4 h of their administration. Under optimized treat-
ment regime, the effect of Omez (3 mg/kg) was margin-
ally better than that of PK (20 mg/kg). Increasing the drug
dose and/or extending the treatment up to seven days led
to a better healing. However, a major part of this can be
attributed to natural recovery, which was substantial on
the 7th day of ulceration.
Tissue damage is always associated with oxidative stress
leading to loss or impairment of protein synthesis and
damages to lipids and the thiol-dependent antioxidant
defense. Besides preventing lipid peroxidation, the sul-
phydryl compounds (thiols) may also protect mucus,
since mucus subunits are joined by disulfide bridges that,
if reduced, render mucus water-soluble [26]. In addition,
they also help in recycling antioxidants like vitamin E and
vitamin C. The decrease in endogenous thiol (glutath-
ione) in ethanol induced gastric injury, and its role in
mucosal protection has been demonstrated [27]. All these
The changes in the tissue EGF expression due to acute gastric ulceration of mice and its regulation by PK and Omez on the 3rd  day of ulceration Figure 5
The changes in the tissue EGF expression due to acute gastric ulceration of mice and its regulation by PK and Omez on the 3rd 
day of ulceration. The EGF immunostaining was carried out using the peroxidase conjugate. Original magnification × 400. a – 
normal mice, b – ulcerated untreated mice, c – ulcerated PK-treated mice, d – ulcerated Omez-treated mice.
Comparative time dependent ability of PK and Omez in regulating PGE2 synthesis in acute gastric ulcerated mice Figure 4
Comparative time dependent ability of PK and Omez in regulating PGE2 synthesis in acute gastric ulcerated mice. The PGE2 lev-
els were measured using ELISA. Data are expressed as means ± S.E.M. for fifteen mice. aP < 0.05, bP < 0.01 compared to normal 
control mice; cP < 0.05 compared to the respective ulcerated mice; dP < 0.05 compared to the Omez-treated mice. N – normal 
mice, UU – ulcerated untreated mice, PK – ulcerated PK-treated mice, Omez – ulcerated Omez-treated mice.BMC Complementary and Alternative Medicine 2008, 8:3 http://www.biomedcentral.com/1472-6882/8/3
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oxidative factors might lead to aggravated tissue damage
during stomach ulceration.
Our results revealed that the stomach ulceration was asso-
ciated with oxidative damages to lipids, proteins and the
thiol-dependent antioxidant defense systems. This was
apparent from the stimulated lipid and protein oxidation
leading to increased accumulation of TBARS and protein
carbonyls as well as depletion of NP-TSH. Indomethacin
induced gastropathy is known to decrease the glutathione
peroxidase activity and aggravate the tissue injury due to
accelerated accumulation of H2O2 and lipid peroxidation.
Furthermore, excessive peroxidation causes increased glu-
tathione consumption [27]. The test samples provided a
suppression of the oxidative damages to the biomacro-
molecules, compared to that observed in natural recovery.
This might decrease the ulcer progression and promote
healing of gastric lesions induced by acute intake of
indomethacin.
Mucosal damage can be easily produced by the generation
of reactive oxygen species. An increase in mucus produc-
tion usually assist the healing process by protecting the
ulcer crater against the endogenous aggressors like, stom-
ach secretions and oxidants as well as exogenous damag-
ing agents, such as NSAIDs. Our results revealed that
stomach ulceration resulted in decreased mucin secretion.
This might reduce the ability of the mucosal membrane to
protect the mucosa from physical damage and back diffu-
sion of hydrogen ions. The ulcer healing by PK and Omez
was associated with an increase in the mucus layer in the
gastric mucosa.
The NSAIDs are known to inhibit cyclooxygenase iso-
forms (COX-1 and COX-2) and decrease the PGE2 levels at
the gastric mucosa causing ulceration [28]. Gastric injury
only develops when both COX-1 and COX-2 are inhib-
ited. Since growth-promoting actions and angiogenesis
play a pivotal role in wound healing, selective cyclooxyge-
nase-2 inhibitors may suppress these activities in gastric
ulcer tissues and delay the healing process. There has been
accumulating evidence that prostaglandin might contrib-
ute to ulcer healing [29].
Our immunohistochemical studies revealed reduced
expression of both COX-1 and COX-2 on the day of ulcer
induction as well as at peak ulceration. Treatment with
PK, but not Omez for three days increased the expression
Comparative time dependent activity of PK and Omez in regulating the expression of tissue EGF in acute gastric ulcerated mice Figure 6
Comparative time dependent activity of PK and Omez in regulating the expression of tissue EGF in acute gastric ulcerated 
mice. The EGF expression was quantified using Biovis MV500 software. Data are expressed as means ± SEM for fifteen mice. aP 
< 0.001 compared to the normal mice; bP < 0.001 compared to the respective ulcerated mice, cP < 0.01 compared to the 
Omez-treated mice. N – normal mice, UU – ulcerated untreated mice, PK – ulcerated PK-treated mice, Omez – ulcerated 
Omez-treated mice.BMC Complementary and Alternative Medicine 2008, 8:3 http://www.biomedcentral.com/1472-6882/8/3
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of both the enzymes significantly. In tune with the above
results, the concentration of mucosal PGE2 was also found
to be reduced on the first day of ulceration itself, which
was depleted further in the mice left untreated. PK aug-
mented the mucosal PGE2 without showing any immedi-
ate effect. The augmentation of the mucosal PGE2 by PK
might stimulate the EP4 receptor-mediated mucin synthe-
sis [30], and inhibit the neutrophil-mediated free radicals
generation [31].
Clinical and experimental data indicate that traditional
NSAIDs delay the healing of gastroduodenal ulcers by
interfering with the action of growth factors that restricts
epithelial cell proliferation, maturation of the granulation
tissue and impede angiogenesis [32]. The growth factor,
Table 3: The effect of PK, Omez, and indomethacin as such and in combination with PK or Omez on the gastric secretion of pylorous 
ligated mice.a 
Mice Gastric juice (ml) (6 h) pH Acid output (μEq/6 h)
Experimental control 0.85 ± 0.1 3.56 183.6 ± 6.8
Treated with PK 0.7 ± 0.1 3.41 179.2 ± 4.6
Treated with indomethacin 1.6 ± 0.2b 2.3 256.6 ± 10.2a
Treated with PK + indomethacin 1.3 ± 0.1c 3.46 206.2 ± 5.9c
Treated with Omez 0.75 ± 0.09 3.36 186.5 ± 6.8c
Treated with Omez + indomethacin 0.9 ± 0.12d 3.25 173.6 ± 6.4c
aUntreated and treated mice were subjected to pylorous ligation. The treatment groups were orally administered PK (20 mg/kg/day × 3 days), 
Omez (3 mg/kg/day × 3 days), indomethacin (18 mg/kg × 1 d) as such or along with PK and Omez at the designated doses. The values are mean ± 
SEM (n = 5). aP < 0.05, bP < 0.01 compared to the experimental control mice cP < 0.05, dP < 0.01 compared to the indomethacin-treated mice
Comparative time dependent activity of PK and Omez in regulating the expression of tissue VEGF in acute gastric ulcerated  mice Figure 7
Comparative time dependent activity of PK and Omez in regulating the expression of tissue VEGF in acute gastric ulcerated 
mice. The EGF expression was quantified using Biovis MV500 software. Data are expressed as means ± SEM for fifteen mice. aP 
< 0.01 compared to normal mice, bP < 0.01 compared to the respective ulcerated mice, cP < 0.01 compared to the Omez-
treated mice. N – normal mice, UU – ulcerated untreated mice, PK – ulcerated PK-treated mice, Omez – ulcerated Omez-
treated mice.BMC Complementary and Alternative Medicine 2008, 8:3 http://www.biomedcentral.com/1472-6882/8/3
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EGF accelerates gastroduodenal ulcer healing by stimulat-
ing cell migration and proliferation in epithelial cell mon-
olayers, tissue repair, increasing release of gastric mucin,
and attenuating gastric acid secretion [33]. EGF is also
reported to stimulate PG synthesis, which, in turn, aug-
ments the expression of EGF via a feedback cycle, medi-
ated by the PKA signaling pathway [34]. The role of the
endogenous EGF in ulcer healing is also unequivocally
confirmed [35].
The present study revealed that gastric ulceration in mice
was associated with a marked increase in the mucosal EGF
level. The increase is expected since ulcer healing would
require more EGF for an effective signal transduction.
However, the increase was significantly lesser compared
to the PK-treated mice. In comparison, Omez altered the
EGF level much less. The endogenous EGF level stimula-
tion by PK is promising for its use as an anti-ulcer agent.
Of the many growth factors, VEGF promotes endothelial
proliferation and migration, and accelerate ulcer healing
[35]. It promotes restoration of the connective tissue and
microvessels (angiogenesis) in injured mucosa.
Indomethacin inhibits ADP-induced platelet aggregation
and release of the α-granule, which stores VEGF. Conse-
quently, indomethacin treatment would reduce VEGF
release. We also observed significantly reduced serum
VEGF level due to ulceration that was reversed by PK, but
much less by Omez.
Amongst the mechanisms involved in prostaglandin
action, stimulation of mucus and cellular growth and
repair as well as regulation of pH at the gastric surface are
important for ulcer healing. The increased production of
mucus, in turn, also enhances the binding of growth fac-
tors with their receptors [36] and contributes to healing.
We found that while Omez had a strong anti-secretary
activity, the effect of PK was much less. Thus, the upregu-
lation of PGE2 by PK might contribute to its healing activ-
ity primarily via increasing the levels of mucin, and other
growth factors, and to a lesser extent due to inhibition to
gastric secretion.
Given that some drugs can show mild-to-severe side
effects even after short-term intake, we also evaluated the
possible toxic effect of PK on mice and found it to be non-
toxic even up to a dose of 500 mg/kg. These findings sug-
gested that PK at the dose used for ulcer-healing does not
have any potential side effects in mice.
Conclusion
Overall, the present study established that PK possesses
significant healing property against indomethacin-
induced stomach ulceration in mice. Its healing action
could be attributed to the antioxidant activity along with
the ability to modulate mucin secretion, PG synthesis,
and upregulation of the growth factors. These results
along with its non-toxicity suggested PK as a promising
anti-ulcerogenic formulation for further evaluation. Con-
sidering the importance of angiogenesis in ulcer healing,
it would be of interest to study the effect of PK on the pro
and anti-angiogenic factors. Investigation in this regard is
currently in progress in our laboratory and the results will
be reported latter.
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